Literature DB >> 33237160

INTESTINAL PERFORATION CAUSED BY COVID-19.

Sergio Carlos Nahas1, José Donizeti de Meira-JÚnior1, Lucas Faraco Sobrado1, Maurício Sorbello1, Vanderlei Segatelli2, Edson Abdala3, Ulysses Ribeiro-JÚnior1, Ivan Cecconello1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33237160      PMCID: PMC7682143          DOI: 10.1590/0102-672020190001e1515

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


× No keyword cloud information.

INTRODUCTION

As the coronavirus disease 2019 (COVID-19) pandemic spreads throughout the world, new clinical manifestations are being reported. In addition to the respiratory manifestations, acute renal failure , hypercoagulability , vomiting and diarrhea have been described. The Cancer Institute of the São Paulo State (ICESP) has already performed over 8500 surgeries for colorectal cancer in the last 10 years. It is one of the hospitals associated with the University of São Paulo School of Medicine, which has already admitted over 3000 patients with moderate or severe COVID-19 for in-hospital treatment. We present a case of intestinal perforation caused by microcirculatory thrombosis in the colon in a patient undergoing surgery for colorectal cancer.

CASE REPORT

A 92-year-old male patient with a diagnosis of rectal adenocarcinoma sought emergency care in April 2020 due to intestinal subocclusion. He had a personal history of hypertension and nondialysis chronic kidney disease. Chest and abdomen CT scans showed no pulmonary changes; multiple liver metastases, the largest one measuring 3.0 cm and distension of the colon and small intestine. He underwent exploratory laparotomy, and a tumor was found in the upper rectum, causing bowel obstruction. A rectosigmoidectomy was performed with blind-ending closure of the rectal stump and terminal colostomy. During the postoperative (PO) period, the patient received food and had intestinal transit until the 3rd PO day, when he started to present coughing and fever. Laboratory testing showed increased C-reactive protein (CRP), as shown in Figure 1. Chest CT scan revealed consolidation in the right lung base. Assessment by the infectious disease team indicated a clinical and radiological profile compatible with bacterial pneumonia. Antibiotic therapy with piperacillin-tazobactam was initiated and maintained for five days with good response, after which the patient started receiving levofloxacin. He was discharged on the 8th PO day, with clinical improvement, decreased CRP levels, good acceptance of food and a functioning colostomy.
FIGURE 1

Serum CRP curve

After two days, on the 10th PO day, he returned to the emergency room complaining of diffuse abdominal pain, oliguria and coughing. Abdominal examination showed a nonfunctioning colostomy and abdominal pain upon palpation, without signs of peritonitis. In the laboratory analysis, the patient had leukocytosis of 19,000 cells/mm³, with 92% neutrophils and a CRP level of 110 mg/l (normal range <5.0 mg/l) in addition to renal dysfunction with an increase in creatinine levels from 1.58 mg/dl to 3.7 mg/dl and an increase in urea from 56 mg/dl to 110 mg/dl. A CT scan of the abdomen showed pneumoperitoneum without free fluid collections and with diffuse distension of small bowel loops. Exploratory laparotomy was indicated and showed punctiform perforation of the descending colon at 5 cm from the colostomy, with fecal peritonitis blocked by small bowel loops. The perforated descending colon segment located at 5 cm from the colostomy was resected, followed by exhaustive washing of the cavity, terminal colostomy and introduction of antibiotic therapy with meropenem. Due to the concomitant pulmonary manifestations, the patient was referred to the ICU intubated with vasoactive drugs, a nasogastric tube, antibiotic therapy and parenteral nutrition. He maintained high nasogastric tube output. Starting on the 1st PO day, he received anticoagulant therapy for the prophylaxis of thromboembolic events. He was extubated on the 3rd PO day and discharged from the ICU. On the 5th PO day, worsening of the respiratory condition was observed, with discomfort, decreased oxygen saturation and increased CRP. The chest CT scan, Figure 2, showed multiple bilateral ground-glass opacities. A D-dimer level of 3225 ng/ml and DHL of 638 U/l were observed. A nasopharyngeal and oropharyngeal swab was collected to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Due to the decrease in oxygen saturation even with 100% oxygen supplementation by mask, the patient was again admitted to the ICU, immediately subjected to orotracheal intubation, and kept on mechanical ventilation and in isolation.
FIGURE 2

Chest CT scan taken on the 5th PO day

Regarding the clinical evolution, the swab was positive, with worsening of general conditions: adynamic ileus, acute renal failure with creatinine reaching 5.0 mg/dl, need for high doses of vasoactive drugs and antibiotic therapy with meropenem, vancomycin and anidulafungin. The patient was extubated on the 28th PO day after improvement of the respiratory condition. He was discharged from the ICU on the 30th PO day but progressed to a coma vigil, according to the neurologist. Death occurred on the 36th PO day. An anatomopathological assessment of the surgical specimen revealed thrombotic changes in the microcirculation of the perforated descending colon (Figure 3).
FIGURE 3

Microscopic findings: A) partial or total necrosis of the intestinal mucosa with edema, inflammation and areas of hemorrhage (4x, H&E); B, C and D) areas of necrosis of adipose tissue and vascular changes, such as congestion and organized thrombi (20x, H&E).

DISCUSSION

We report the case of a patient who underwent emergency surgical treatment for colorectal cancer without signs or symptoms of COVID-19. At the time of admission, there was no suspicion of COVID-19, and a nasopharyngeal and oropharyngeal swab was not collected for RT-PCR screening for the virus. However, during the PO evolution of the disease, when the patient began to show signs and symptoms compatible with COVID-19, testing was performed, and SARS-CoV-2 infection was confirmed; the infection led to renal, pulmonary and gastrointestinal complications, which led to the his death. The patient’s severe respiratory symptoms were reversed with intensive support and multidisciplinary treatment; the most significant factor in the unfavorable outcome of the case was the involvement of the digestive tract, with intestinal perforation, abdominal sepsis and multiple organ dysfunction secondary to the infectious process. Gastrointestinal symptoms such as diarrhea, nausea and vomiting have been described in COVID-19 patients; they can occur even in the absence of respiratory symptoms and are related to intestinal inflammation caused by the viral process. To the best of our knowledge, this is the first report in the literature of intestinal perforation resulting from microcirculation thrombosis associated with SARS-CoV-2 infection with histopathological evaluation. In addition to respiratory and gastrointestinal symptoms, SARS-CoV-2 infection produces an inflammatory response triggered by rapid viral replication and cell destruction, resulting in the recruitment of macrophages and monocytes and inducing the release of cytokines and chemokines such as IL-1β, IL-2, IL-6, IL-7 and IFN-γ . These cytokines induce the formation of thrombin through the release of tissue factors by endothelial cells and the disruption of natural anticoagulant mechanisms. In addition, fibrinolysis is impaired by the increase in plasminogen activator inhibitor 1, which impairs fibrin clearance - . Thus, this cytokine storm eventually induces activation of the coagulation cascade, causing thrombotic phenomena, which may manifest in various vascular territories. Arteriolar thrombi have been described in the pulmonary microcirculation in both areas of normal lung parenchyma and areas of tissue damaged by the effects of the virus. A study by our Department of Pathology demonstrated the benefit of anticoagulant therapy for improving the oxygenation of critical patients, and this procedure was applied in the reported case. We found in the literature a report of acute intestinal necrosis secondary to the microcirculatory thrombotic effects of the new coronavirus. In addition to pulmonary and intestinal thrombosis, there was a significant increase in the incidence of deep vein thrombosis in ICU patients due to COVID-19; the incidence reached 85%, even when prophylactic anticoagulants were used8. Skin lesions have been described in patients with a severe form of COVID-19 as a result of thrombotic disorders . The arteriolar thrombi visualized in this case and represented in Figure 3 are similar to the thrombi in the pulmonary circulation described in autopsies of patients who died from COVID-19. The macroscopic study of the surgical sample showed a segment of the colon measuring 4.5 cm in length with serosa containing fibrinous material. The intestinal wall was thin and had a focal perforation area. The mucosa was hemorrhagic. In the microscopic findings, we observed changes in the ischemic pattern with partial or total necrosis of the intestinal wall and areas of mucous loss, edema, inflammation and hemorrhage. In the subserosa, necrosis of the adipose tissue with congestion and several organized vascular thrombi (Figure 3). Most likely, the intestinal microcirculatory thrombosis observed in the presented case led to ischemia of the colon wall, culminating in intestinal perforation, which caused the need for surgical re-exploration. Considering the observation of the potential complications caused by COVID-19 in the PO period, the hospital infection control committee began collecting swabs to screen for SARS-COV-2 in all patients before emergency surgical procedures. For elective surgeries, tests are performed 48 h before the procedure, and if positive, surgery is postponed whenever possible.
  11 in total

1.  Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan.

Authors:  Bin Ren; Feifei Yan; Zhouming Deng; Sheng Zhang; Meng Wu; Lin Cai; Lingfei Xiao
Journal:  Circulation       Date:  2020-05-15       Impact factor: 29.690

2.  [Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia].

Authors:  Y Zhang; W Cao; M Xiao; Y J Li; Y Yang; J Zhao; X Zhou; W Jiang; Y Q Zhao; S Y Zhang; T S Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-03-28

3.  Faecal calprotectin indicates intestinal inflammation in COVID-19.

Authors:  Maria Effenberger; Felix Grabherr; Lisa Mayr; Julian Schwaerzler; Manfred Nairz; Markus Seifert; Richard Hilbe; Stefanie Seiwald; Sabine Scholl-Buergi; Gernot Fritsche; Rosa Bellmann-Weiler; Günter Weiss; Thomas Müller; Timon Erik Adolph; Herbert Tilg
Journal:  Gut       Date:  2020-04-20       Impact factor: 23.059

4.  COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.

Authors:  Luca Spiezia; Annalisa Boscolo; Francesco Poletto; Lorenzo Cerruti; Ivo Tiberio; Elena Campello; Paolo Navalesi; Paolo Simioni
Journal:  Thromb Haemost       Date:  2020-04-21       Impact factor: 5.249

5.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

Review 6.  The trinity of COVID-19: immunity, inflammation and intervention.

Authors:  Matthew Zirui Tay; Chek Meng Poh; Laurent Rénia; Paul A MacAry; Lisa F P Ng
Journal:  Nat Rev Immunol       Date:  2020-04-28       Impact factor: 108.555

7.  Bowel Necrosis in the Setting of COVID-19.

Authors:  Rajshri M Gartland; George C Velmahos
Journal:  J Gastrointest Surg       Date:  2020-05-03       Impact factor: 3.267

8.  Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.

Authors:  Xi Jin; Jiang-Shan Lian; Jian-Hua Hu; Jianguo Gao; Lin Zheng; Yi-Min Zhang; Shao-Rui Hao; Hong-Yu Jia; Huan Cai; Xiao-Li Zhang; Guo-Dong Yu; Kai-Jin Xu; Xiao-Yan Wang; Jue-Qing Gu; Shan-Yan Zhang; Chan-Yuan Ye; Ci-Liang Jin; Ying-Feng Lu; Xia Yu; Xiao-Peng Yu; Jian-Rong Huang; Kang-Li Xu; Qin Ni; Cheng-Bo Yu; Biao Zhu; Yong-Tao Li; Jun Liu; Hong Zhao; Xuan Zhang; Liang Yu; Yong-Zheng Guo; Jun-Wei Su; Jing-Jing Tao; Guan-Jing Lang; Xiao-Xin Wu; Wen-Rui Wu; Ting-Ting Qv; Dai-Rong Xiang; Ping Yi; Ding Shi; Yanfei Chen; Yue Ren; Yun-Qing Qiu; Lan-Juan Li; Jifang Sheng; Yida Yang
Journal:  Gut       Date:  2020-03-24       Impact factor: 23.059

9.  Heparin Therapy Improving Hypoxia in COVID-19 Patients - A Case Series.

Authors:  Elnara Marcia Negri; Bruna Mamprim Piloto; Luciana Kato Morinaga; Carlos Viana Poyares Jardim; Shari Anne El-Dash Lamy; Marcelo Alves Ferreira; Elbio Antonio D'Amico; Daniel Deheinzelin
Journal:  Front Physiol       Date:  2020-10-19       Impact factor: 4.566

10.  Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19.

Authors:  Marisa Dolhnikoff; Amaro Nunes Duarte-Neto; Renata Aparecida de Almeida Monteiro; Luiz Fernando Ferraz da Silva; Ellen Pierre de Oliveira; Paulo Hilário Nascimento Saldiva; Thais Mauad; Elnara Marcia Negri
Journal:  J Thromb Haemost       Date:  2020-06       Impact factor: 16.036

View more
  6 in total

1.  RESULTS OF SURGICAL TREATMENT OF COLORECTAL CANCER, ELECTIVE AND EMERGENCY, IN PATIENTS WITH COVID-19.

Authors:  Sergio Carlos Nahas; José Donizeti de Meira Júnior; Caio Sergio Rizkallah Nahas; Lucas Faraco Sobrado; Rodrigo Ambar Pinto; Edson Abdala; Ulysses Ribeiro Junior; Ivan Cecconello
Journal:  Arq Bras Cir Dig       Date:  2022-06-17

2.  Outcome of percutaneous drainage for septic complications coexisted with COVID-19.

Authors:  Mohamed A Deif; Ahmad M Mounir; Sherif A Abo-Hedibah; Ahmed M Abdel Khalek; Ali H Elmokadem
Journal:  World J Radiol       Date:  2022-04-28

3.  Is it Safe to Perform Elective Colorectal Surgical Procedures during the COVID-19 Pandemic? A Single Institution Experience with 103 Patients.

Authors:  Lucas Faraco Sobrado; Caio Sergio Rizkallah Nahas; Carlos Frederico Sparapan Marques; Guilherme Cutait de Castro Cotti; Antônio Rocco Imperiale; Pedro Averbach; José Donizeti de Meira Júnior; Natally Horvat; Ulysses Ribeiro-Júnior; Ivan Cecconello; Sergio Carlos Nahas
Journal:  Clinics (Sao Paulo)       Date:  2021-03-24       Impact factor: 2.365

Review 4.  GASTROINTESTINAL COMPLICATIONS OF CORONAVIRUS DISEASE (COVID-19).

Authors:  Marcelo Augusto Fontenelle Ribeiro-Junior; Samara de Souza Augusto; Yasmin Garcia Batista Elias; Cássia Tiemi Kawase Costa; Paola Rezende Néder
Journal:  Arq Bras Cir Dig       Date:  2022-01-05

Review 5.  COVID 19 and the risk of gastro-intestinal perforation: A case series and literature review.

Authors:  Joris Paul Bulte; Nynke Postma; Menno Beukema; Bas Inberg; Abe Gerrit Stegeman; Hans van der Hoeven
Journal:  J Crit Care       Date:  2021-11-02       Impact factor: 3.425

6.  Colon perforation as a complication of COVID-19: a case report.

Authors:  Keita Nakatsutsumi; Akira Endo; Hiraaki Okuzawa; Iichiro Onishi; Anri Koyanagi; Eiki Nagaoka; Koji Morishita; Junichi Aiboshi; Yasuhiro Otomo
Journal:  Surg Case Rep       Date:  2021-08-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.